Acorn Asks For More Help From Investors After FDA Panel Denies CorCap PMA
This article was originally published in The Gray Sheet
Executive Summary
Acorn Cardiovascular says it will ask its current investors to fund a confirmatory trial of its CorCap Cardiac Support Device after an FDA advisory panel decided more research is needed before it could support premarket approval